Sydney, Kirby Institute, 2026.
Summarises trends in hepatitis C treatment, providing key insights into Australia’s progress towards hepatitis C elimination.
Adelaide, Hepatitis SA, 2026.
Hep D can only live alongside HBV. The two viruses in combination are the most lethal of all hepatitis infections making it crucial that people with HBV are tested for HDV.
Sydney, Hepatitis NSW, 2026.
Information for communities affected by hepatitis B. Our message is simple but powerful: knowing your hep B status, talking with family and staying connected to care can help prevent liver cancer.
Melbourne, John Wiley & Son, 2026.
Examined health-related quality of life and fatigue at different disease stages and found significant impacts, particularly at later disease stages.
Melbourne, John Wiley & Son, 2025.
Point-of-care testing for hepatitis C virus (HCV) offers multiple benefits to key populations and healthcare providers, but it has not achieved widespread implementation. Study found that integration into existing health system structures, sustainable funding mechanisms, and strengthened governance frameworks are needed to sustain HCV point-of-care testing in Australia.
London, Elsevier, 2026.
Australian community pharmacies demonstrate high engagement with harm reduction services, despite jurisdictional differences for some services. Financially incentivised policies appeared to facilitate uptake. Findings highlight the role of enablers in pharmacy-based harm reduction and offer insights to expand uptake, locally and internationally.
Zurich, INHSU, 2026.
Incentives can help create opportunities for engagement, but trust, relationships, flexibility and addressing practical barriers remain the foundations of successful models.
Boston, Clinton Health Access Initiative, 2026.
These programs have screened 25.4 million people, cured an estimated 473,000, and helped drive the cost of a complete HCV cure down by over 88 percent.
Sydney, Hepatitis NSW, 2026.
In this edition Jono is keen for Adam to join the local Men's Shed. But Adam isn't into the idea. He's also not into talking about his health. Jono doesn't give up and soon Adam finds himself doing more talking than he could ever imagine. Our second story introduces us to Gerrard and his passion - ten pin bowling. But when that passion is threatened by hep C, he starts researching. It doesn't take him long to find our website and the answers he seeks.
Melbourne, John Wiley & Son, 2026.
To achieve hepatitis B virus (HBV) elimination in Australia, a shift from hospital to community-based care is needed. Our data show that significant gaps in the cascade of care remain for people with chronic HBV in primary care settings.
Melbourne, John Wiley and Son, 2026.
Current uptake of chronic hepatitis B (CHB) treatment and care in Australia is well below target levels, leading to an ongoing burden of preventable liver disease and cancer. Understanding individual-level trajectories of care engagement and variation by sociodemographic factors is essential to guide efforts to improve access to and retention in care.
Adelaide, Hepatitis SA, 2026.
A functional cure is a finite treatment that gets someone living with hepatitis B to the same state as someone who has naturally cleared the virus. Discusses the development of possible treatments.
Zurich, INHSU, 2026.
Eliminating hepatitis C is no longer a question of what works, but how to make it work in practice. International experts share practical lessons on simplifying testing, strengthening patient navigation and peer support, and implementing models of care that improve access to hepatitis C treatment.
London, British Liver Trust, 2026.
Laura Haigh, a Specialist non-alcohol related fatty liver disease (NAFLD) Dietitian gives tips and advice on healthy eating.
Melbourne, LiverWELL (Hepatitis Victoria), 2019.
Causes, outcomes, treatment and management of alcohol-related liver disease.
Bexhill-on-Sea, Medical News Today, 2024,
Because the liver plays a vital role in digestion and nutrient absorption, individuals with cirrhosis are at risk of malnutrition. Dietary changes can help reduce this risk. Discusses the best foods and mealtimes for people with cirrhosis and some foods that people with cirrhosis may want to avoid in order to help prevent cirrhosis complications.
Melbourne, LiverWELL (Hepatitis Victoria), 2019.
Causes, outcomes, treatment and management of fatty liver disease.
Melbourne, John Wiley & Son, 2026.
London, Elsevier, 2025.
Hepatitis-related stigma can affect people at individual, interpersonal, community, and professional levels. Marginalised groups are disproportionately affected by viral hepatitis, which can amplify the impact of enacted stigma. The resultant discrimination and prejudice can lead to mental health impacts, reduce quality of life and prevent people seeking care.
Geneva, World Health Organization, 2026.
he latest data suggests progress is mixed and the world is off track to reach the 2030 targets for HIV, viral hepatitis and STIs.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.